nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminophylline—CYP2E1—type 2 diabetes mellitus	0.176	0.387	CbGaD
Aminophylline—CYP1A2—type 2 diabetes mellitus	0.168	0.369	CbGaD
Aminophylline—CYP3A4—type 2 diabetes mellitus	0.111	0.244	CbGaD
Aminophylline—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0294	0.113	CbGbCtD
Aminophylline—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0259	0.0999	CbGbCtD
Aminophylline—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0231	0.0893	CbGbCtD
Aminophylline—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0231	0.089	CbGbCtD
Aminophylline—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0219	0.0844	CbGbCtD
Aminophylline—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0211	0.0814	CbGbCtD
Aminophylline—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0184	0.0712	CbGbCtD
Aminophylline—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0167	0.0644	CbGbCtD
Aminophylline—CYP1A2—Losartan—type 2 diabetes mellitus	0.0149	0.0575	CbGbCtD
Aminophylline—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0126	0.0488	CbGbCtD
Aminophylline—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0121	0.0468	CbGbCtD
Aminophylline—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0121	0.0468	CbGbCtD
Aminophylline—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0115	0.0442	CbGbCtD
Aminophylline—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00853	0.0329	CbGbCtD
Aminophylline—CYP3A4—Losartan—type 2 diabetes mellitus	0.00781	0.0301	CbGbCtD
Aminophylline—PDE3A—penis—type 2 diabetes mellitus	0.00593	0.203	CbGeAlD
Aminophylline—ADORA1—nerve—type 2 diabetes mellitus	0.00265	0.0906	CbGeAlD
Aminophylline—HDAC2—islet of Langerhans—type 2 diabetes mellitus	0.00127	0.0434	CbGeAlD
Aminophylline—ADORA2B—adipose tissue—type 2 diabetes mellitus	0.00114	0.039	CbGeAlD
Aminophylline—HDAC2—retina—type 2 diabetes mellitus	0.00109	0.0371	CbGeAlD
Aminophylline—ADORA2A—cardiovascular system—type 2 diabetes mellitus	0.00108	0.0368	CbGeAlD
Aminophylline—HDAC2—nephron tubule—type 2 diabetes mellitus	0.00102	0.0349	CbGeAlD
Aminophylline—PDE4A—adipose tissue—type 2 diabetes mellitus	0.00102	0.0347	CbGeAlD
Aminophylline—PDE3A—cardiovascular system—type 2 diabetes mellitus	0.000954	0.0326	CbGeAlD
Aminophylline—ADORA1—cardiovascular system—type 2 diabetes mellitus	0.000929	0.0318	CbGeAlD
Aminophylline—HDAC2—cardiovascular system—type 2 diabetes mellitus	0.000918	0.0314	CbGeAlD
Aminophylline—ADORA1—kidney—type 2 diabetes mellitus	0.000909	0.0311	CbGeAlD
Aminophylline—HDAC2—kidney—type 2 diabetes mellitus	0.000898	0.0307	CbGeAlD
Aminophylline—HDAC2—pancreas—type 2 diabetes mellitus	0.000892	0.0305	CbGeAlD
Aminophylline—ADORA1—cortex of kidney—type 2 diabetes mellitus	0.000886	0.0303	CbGeAlD
Aminophylline—HDAC2—cortex of kidney—type 2 diabetes mellitus	0.000875	0.0299	CbGeAlD
Aminophylline—PDE3A—adipose tissue—type 2 diabetes mellitus	0.000841	0.0287	CbGeAlD
Aminophylline—ADORA1—adipose tissue—type 2 diabetes mellitus	0.00082	0.028	CbGeAlD
Aminophylline—HDAC2—adipose tissue—type 2 diabetes mellitus	0.00081	0.0277	CbGeAlD
Aminophylline—Theophylline—CYP2E1—type 2 diabetes mellitus	0.000688	0.387	CrCbGaD
Aminophylline—ADORA2A—liver—type 2 diabetes mellitus	0.000666	0.0227	CbGeAlD
Aminophylline—Theophylline—CYP1A2—type 2 diabetes mellitus	0.000655	0.368	CrCbGaD
Aminophylline—PDE3A—liver—type 2 diabetes mellitus	0.00059	0.0202	CbGeAlD
Aminophylline—HDAC2—liver—type 2 diabetes mellitus	0.000568	0.0194	CbGeAlD
Aminophylline—Theophylline—CYP3A4—type 2 diabetes mellitus	0.000434	0.244	CrCbGaD
Aminophylline—CYP2E1—nephron tubule—type 2 diabetes mellitus	0.000423	0.0144	CbGeAlD
Aminophylline—CYP2E1—cardiovascular system—type 2 diabetes mellitus	0.00038	0.013	CbGeAlD
Aminophylline—CYP2E1—kidney—type 2 diabetes mellitus	0.000372	0.0127	CbGeAlD
Aminophylline—CYP2E1—cortex of kidney—type 2 diabetes mellitus	0.000362	0.0124	CbGeAlD
Aminophylline—CYP3A4—kidney—type 2 diabetes mellitus	0.000299	0.0102	CbGeAlD
Aminophylline—CYP1A2—liver—type 2 diabetes mellitus	0.000261	0.00892	CbGeAlD
Aminophylline—CYP2E1—liver—type 2 diabetes mellitus	0.000235	0.00803	CbGeAlD
Aminophylline—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000222	0.00148	CcSEcCtD
Aminophylline—Flushing—Metformin—type 2 diabetes mellitus	0.000222	0.00148	CcSEcCtD
Aminophylline—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000222	0.00148	CcSEcCtD
Aminophylline—Palpitations—Gliclazide—type 2 diabetes mellitus	0.00022	0.00147	CcSEcCtD
Aminophylline—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000218	0.00145	CcSEcCtD
Aminophylline—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000218	0.00145	CcSEcCtD
Aminophylline—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000218	0.00145	CcSEcCtD
Aminophylline—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000217	0.00145	CcSEcCtD
Aminophylline—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000217	0.00145	CcSEcCtD
Aminophylline—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000217	0.00144	CcSEcCtD
Aminophylline—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000216	0.00144	CcSEcCtD
Aminophylline—Anorexia—Glyburide—type 2 diabetes mellitus	0.000216	0.00144	CcSEcCtD
Aminophylline—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000216	0.00144	CcSEcCtD
Aminophylline—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000212	0.00141	CcSEcCtD
Aminophylline—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000212	0.00141	CcSEcCtD
Aminophylline—Hypotension—Glyburide—type 2 diabetes mellitus	0.000212	0.00141	CcSEcCtD
Aminophylline—Anxiety—Gliclazide—type 2 diabetes mellitus	0.000212	0.00141	CcSEcCtD
Aminophylline—Nausea—Repaglinide—type 2 diabetes mellitus	0.000211	0.00141	CcSEcCtD
Aminophylline—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000211	0.0014	CcSEcCtD
Aminophylline—Flushing—Irbesartan—type 2 diabetes mellitus	0.00021	0.0014	CcSEcCtD
Aminophylline—Pruritus—Glipizide—type 2 diabetes mellitus	0.000208	0.00139	CcSEcCtD
Aminophylline—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000208	0.00138	CcSEcCtD
Aminophylline—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000203	0.00135	CcSEcCtD
Aminophylline—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000202	0.00135	CcSEcCtD
Aminophylline—Palpitations—Valsartan—type 2 diabetes mellitus	0.000202	0.00135	CcSEcCtD
Aminophylline—Infection—Gliclazide—type 2 diabetes mellitus	0.000202	0.00135	CcSEcCtD
Aminophylline—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.000202	0.00135	CcSEcCtD
Aminophylline—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000202	0.00134	CcSEcCtD
Aminophylline—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000202	0.00134	CcSEcCtD
Aminophylline—Palpitations—Orlistat—type 2 diabetes mellitus	0.0002	0.00133	CcSEcCtD
Aminophylline—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.0002	0.00133	CcSEcCtD
Aminophylline—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.0002	0.00133	CcSEcCtD
Aminophylline—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.0002	0.00133	CcSEcCtD
Aminophylline—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000199	0.00132	CcSEcCtD
Aminophylline—Flushing—Losartan—type 2 diabetes mellitus	0.000198	0.00132	CcSEcCtD
Aminophylline—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000197	0.00131	CcSEcCtD
Aminophylline—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000197	0.00131	CcSEcCtD
Aminophylline—Convulsion—Orlistat—type 2 diabetes mellitus	0.000196	0.00131	CcSEcCtD
Aminophylline—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000196	0.00131	CcSEcCtD
Aminophylline—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000196	0.00131	CcSEcCtD
Aminophylline—Tremor—Metformin—type 2 diabetes mellitus	0.000195	0.0013	CcSEcCtD
Aminophylline—Dizziness—Glipizide—type 2 diabetes mellitus	0.000195	0.0013	CcSEcCtD
Aminophylline—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000194	0.0013	CcSEcCtD
Aminophylline—Anxiety—Valsartan—type 2 diabetes mellitus	0.000194	0.0013	CcSEcCtD
Aminophylline—Tension—Irbesartan—type 2 diabetes mellitus	0.000193	0.00129	CcSEcCtD
Aminophylline—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000193	0.00129	CcSEcCtD
Aminophylline—Anxiety—Orlistat—type 2 diabetes mellitus	0.000192	0.00128	CcSEcCtD
Aminophylline—Nervousness—Irbesartan—type 2 diabetes mellitus	0.000191	0.00127	CcSEcCtD
Aminophylline—Hypotension—Gliclazide—type 2 diabetes mellitus	0.00019	0.00127	CcSEcCtD
Aminophylline—Arrhythmia—Losartan—type 2 diabetes mellitus	0.00019	0.00127	CcSEcCtD
Aminophylline—CYP3A4—liver—type 2 diabetes mellitus	0.000189	0.00646	CbGeAlD
Aminophylline—Alopecia—Losartan—type 2 diabetes mellitus	0.000188	0.00125	CcSEcCtD
Aminophylline—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000188	0.00125	CcSEcCtD
Aminophylline—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000187	0.00125	CcSEcCtD
Aminophylline—Vomiting—Glipizide—type 2 diabetes mellitus	0.000187	0.00125	CcSEcCtD
Aminophylline—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000187	0.00125	CcSEcCtD
Aminophylline—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000187	0.00124	CcSEcCtD
Aminophylline—Infection—Valsartan—type 2 diabetes mellitus	0.000186	0.00124	CcSEcCtD
Aminophylline—Rash—Glipizide—type 2 diabetes mellitus	0.000186	0.00124	CcSEcCtD
Aminophylline—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000186	0.00124	CcSEcCtD
Aminophylline—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000185	0.00123	CcSEcCtD
Aminophylline—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000185	0.00123	CcSEcCtD
Aminophylline—Headache—Glipizide—type 2 diabetes mellitus	0.000185	0.00123	CcSEcCtD
Aminophylline—Tremor—Irbesartan—type 2 diabetes mellitus	0.000184	0.00123	CcSEcCtD
Aminophylline—Palpitations—Metformin—type 2 diabetes mellitus	0.000184	0.00123	CcSEcCtD
Aminophylline—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000184	0.00123	CcSEcCtD
Aminophylline—Shock—Valsartan—type 2 diabetes mellitus	0.000184	0.00123	CcSEcCtD
Aminophylline—Infection—Orlistat—type 2 diabetes mellitus	0.000184	0.00122	CcSEcCtD
Aminophylline—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000183	0.00122	CcSEcCtD
Aminophylline—Tension—Losartan—type 2 diabetes mellitus	0.000182	0.00121	CcSEcCtD
Aminophylline—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000182	0.00121	CcSEcCtD
Aminophylline—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000181	0.00121	CcSEcCtD
Aminophylline—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000181	0.00121	CcSEcCtD
Aminophylline—Agitation—Irbesartan—type 2 diabetes mellitus	0.000181	0.00121	CcSEcCtD
Aminophylline—Urticaria—Glyburide—type 2 diabetes mellitus	0.00018	0.0012	CcSEcCtD
Aminophylline—Nervousness—Losartan—type 2 diabetes mellitus	0.00018	0.0012	CcSEcCtD
Aminophylline—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000179	0.00119	CcSEcCtD
Aminophylline—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000179	0.00119	CcSEcCtD
Aminophylline—Anorexia—Valsartan—type 2 diabetes mellitus	0.000178	0.00119	CcSEcCtD
Aminophylline—Headache—Pioglitazone—type 2 diabetes mellitus	0.000177	0.00118	CcSEcCtD
Aminophylline—Nausea—Glipizide—type 2 diabetes mellitus	0.000175	0.00117	CcSEcCtD
Aminophylline—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000175	0.00116	CcSEcCtD
Aminophylline—Hypotension—Valsartan—type 2 diabetes mellitus	0.000175	0.00116	CcSEcCtD
Aminophylline—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000174	0.00116	CcSEcCtD
Aminophylline—Tremor—Losartan—type 2 diabetes mellitus	0.000174	0.00116	CcSEcCtD
Aminophylline—Rash—Glimepiride—type 2 diabetes mellitus	0.000173	0.00115	CcSEcCtD
Aminophylline—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000173	0.00115	CcSEcCtD
Aminophylline—Rash—Sitagliptin—type 2 diabetes mellitus	0.000173	0.00115	CcSEcCtD
Aminophylline—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000173	0.00115	CcSEcCtD
Aminophylline—Headache—Glimepiride—type 2 diabetes mellitus	0.000172	0.00115	CcSEcCtD
Aminophylline—Headache—Sitagliptin—type 2 diabetes mellitus	0.000172	0.00114	CcSEcCtD
Aminophylline—Agitation—Losartan—type 2 diabetes mellitus	0.00017	0.00113	CcSEcCtD
Aminophylline—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.00017	0.00113	CcSEcCtD
Aminophylline—Flushing—Ramipril—type 2 diabetes mellitus	0.000169	0.00113	CcSEcCtD
Aminophylline—Infection—Metformin—type 2 diabetes mellitus	0.000169	0.00113	CcSEcCtD
Aminophylline—Insomnia—Valsartan—type 2 diabetes mellitus	0.000169	0.00113	CcSEcCtD
Aminophylline—Shock—Metformin—type 2 diabetes mellitus	0.000168	0.00112	CcSEcCtD
Aminophylline—Insomnia—Orlistat—type 2 diabetes mellitus	0.000167	0.00111	CcSEcCtD
Aminophylline—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000167	0.00111	CcSEcCtD
Aminophylline—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000167	0.00111	CcSEcCtD
Aminophylline—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000167	0.00111	CcSEcCtD
Aminophylline—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000166	0.00111	CcSEcCtD
Aminophylline—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000165	0.0011	CcSEcCtD
Aminophylline—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000164	0.00109	CcSEcCtD
Aminophylline—Palpitations—Losartan—type 2 diabetes mellitus	0.000164	0.00109	CcSEcCtD
Aminophylline—Nausea—Glimepiride—type 2 diabetes mellitus	0.000163	0.00109	CcSEcCtD
Aminophylline—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000163	0.00109	CcSEcCtD
Aminophylline—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000163	0.00108	CcSEcCtD
Aminophylline—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000163	0.00108	CcSEcCtD
Aminophylline—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000163	0.00108	CcSEcCtD
Aminophylline—Anorexia—Metformin—type 2 diabetes mellitus	0.000162	0.00108	CcSEcCtD
Aminophylline—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000162	0.00108	CcSEcCtD
Aminophylline—Alopecia—Ramipril—type 2 diabetes mellitus	0.000161	0.00107	CcSEcCtD
Aminophylline—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000161	0.00107	CcSEcCtD
Aminophylline—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000161	0.00107	CcSEcCtD
Aminophylline—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000161	0.00107	CcSEcCtD
Aminophylline—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000161	0.00107	CcSEcCtD
Aminophylline—Pruritus—Glyburide—type 2 diabetes mellitus	0.00016	0.00107	CcSEcCtD
Aminophylline—Infection—Irbesartan—type 2 diabetes mellitus	0.00016	0.00106	CcSEcCtD
Aminophylline—Hypotension—Metformin—type 2 diabetes mellitus	0.000159	0.00106	CcSEcCtD
Aminophylline—Shock—Irbesartan—type 2 diabetes mellitus	0.000158	0.00105	CcSEcCtD
Aminophylline—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000158	0.00105	CcSEcCtD
Aminophylline—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000158	0.00105	CcSEcCtD
Aminophylline—Anxiety—Losartan—type 2 diabetes mellitus	0.000157	0.00105	CcSEcCtD
Aminophylline—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000157	0.00104	CcSEcCtD
Aminophylline—Rash—Bromocriptine—type 2 diabetes mellitus	0.000156	0.00104	CcSEcCtD
Aminophylline—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000156	0.00104	CcSEcCtD
Aminophylline—Tension—Ramipril—type 2 diabetes mellitus	0.000156	0.00104	CcSEcCtD
Aminophylline—Headache—Bromocriptine—type 2 diabetes mellitus	0.000155	0.00103	CcSEcCtD
Aminophylline—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000155	0.00103	CcSEcCtD
Aminophylline—Nervousness—Ramipril—type 2 diabetes mellitus	0.000154	0.00103	CcSEcCtD
Aminophylline—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000153	0.00102	CcSEcCtD
Aminophylline—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000153	0.00102	CcSEcCtD
Aminophylline—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000151	0.00101	CcSEcCtD
Aminophylline—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000151	0.00101	CcSEcCtD
Aminophylline—Infection—Losartan—type 2 diabetes mellitus	0.00015	0.001	CcSEcCtD
Aminophylline—Hypotension—Irbesartan—type 2 diabetes mellitus	0.00015	0.001	CcSEcCtD
Aminophylline—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.00015	0.000999	CcSEcCtD
Aminophylline—Dyspepsia—Metformin—type 2 diabetes mellitus	0.00015	0.000999	CcSEcCtD
Aminophylline—Tremor—Ramipril—type 2 diabetes mellitus	0.000149	0.000992	CcSEcCtD
Aminophylline—Shock—Losartan—type 2 diabetes mellitus	0.000149	0.000991	CcSEcCtD
Aminophylline—Urticaria—Valsartan—type 2 diabetes mellitus	0.000149	0.00099	CcSEcCtD
Aminophylline—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000148	0.000988	CcSEcCtD
Aminophylline—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000148	0.000986	CcSEcCtD
Aminophylline—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000148	0.000985	CcSEcCtD
Aminophylline—Tachycardia—Losartan—type 2 diabetes mellitus	0.000148	0.000983	CcSEcCtD
Aminophylline—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000147	0.000981	CcSEcCtD
Aminophylline—Urticaria—Orlistat—type 2 diabetes mellitus	0.000147	0.000978	CcSEcCtD
Aminophylline—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000146	0.000973	CcSEcCtD
Aminophylline—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000146	0.000973	CcSEcCtD
Aminophylline—Agitation—Ramipril—type 2 diabetes mellitus	0.000146	0.000973	CcSEcCtD
Aminophylline—Anorexia—Losartan—type 2 diabetes mellitus	0.000144	0.00096	CcSEcCtD
Aminophylline—Vomiting—Glyburide—type 2 diabetes mellitus	0.000144	0.00096	CcSEcCtD
Aminophylline—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000144	0.000959	CcSEcCtD
Aminophylline—Rash—Glyburide—type 2 diabetes mellitus	0.000143	0.000952	CcSEcCtD
Aminophylline—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000143	0.000951	CcSEcCtD
Aminophylline—Headache—Glyburide—type 2 diabetes mellitus	0.000142	0.000946	CcSEcCtD
Aminophylline—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000141	0.000942	CcSEcCtD
Aminophylline—Hypotension—Losartan—type 2 diabetes mellitus	0.000141	0.000941	CcSEcCtD
Aminophylline—Palpitations—Ramipril—type 2 diabetes mellitus	0.00014	0.000935	CcSEcCtD
Aminophylline—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.00014	0.000931	CcSEcCtD
Aminophylline—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000139	0.000928	CcSEcCtD
Aminophylline—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000139	0.000928	CcSEcCtD
Aminophylline—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000138	0.000918	CcSEcCtD
Aminophylline—Convulsion—Ramipril—type 2 diabetes mellitus	0.000138	0.000917	CcSEcCtD
Aminophylline—Insomnia—Losartan—type 2 diabetes mellitus	0.000137	0.000911	CcSEcCtD
Aminophylline—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000136	0.000907	CcSEcCtD
Aminophylline—Urticaria—Metformin—type 2 diabetes mellitus	0.000135	0.000901	CcSEcCtD
Aminophylline—Anxiety—Ramipril—type 2 diabetes mellitus	0.000135	0.000898	CcSEcCtD
Aminophylline—Nausea—Glyburide—type 2 diabetes mellitus	0.000135	0.000897	CcSEcCtD
Aminophylline—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000135	0.000897	CcSEcCtD
Aminophylline—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000135	0.000897	CcSEcCtD
Aminophylline—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000133	0.000887	CcSEcCtD
Aminophylline—Pruritus—Valsartan—type 2 diabetes mellitus	0.000132	0.000881	CcSEcCtD
Aminophylline—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000131	0.000876	CcSEcCtD
Aminophylline—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000131	0.000875	CcSEcCtD
Aminophylline—Pruritus—Orlistat—type 2 diabetes mellitus	0.000131	0.000871	CcSEcCtD
Aminophylline—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.00013	0.000864	CcSEcCtD
Aminophylline—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000129	0.000862	CcSEcCtD
Aminophylline—Rash—Gliclazide—type 2 diabetes mellitus	0.000128	0.000855	CcSEcCtD
Aminophylline—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000128	0.000854	CcSEcCtD
Aminophylline—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000128	0.000852	CcSEcCtD
Aminophylline—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000128	0.00085	CcSEcCtD
Aminophylline—Shock—Ramipril—type 2 diabetes mellitus	0.000128	0.00085	CcSEcCtD
Aminophylline—Headache—Gliclazide—type 2 diabetes mellitus	0.000128	0.000849	CcSEcCtD
Aminophylline—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000127	0.000847	CcSEcCtD
Aminophylline—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000127	0.000846	CcSEcCtD
Aminophylline—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000127	0.000846	CcSEcCtD
Aminophylline—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000127	0.000843	CcSEcCtD
Aminophylline—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000126	0.000842	CcSEcCtD
Aminophylline—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000124	0.000824	CcSEcCtD
Aminophylline—Dizziness—Valsartan—type 2 diabetes mellitus	0.000124	0.000824	CcSEcCtD
Aminophylline—Anorexia—Ramipril—type 2 diabetes mellitus	0.000124	0.000823	CcSEcCtD
Aminophylline—Dizziness—Orlistat—type 2 diabetes mellitus	0.000122	0.000814	CcSEcCtD
Aminophylline—Hypotension—Ramipril—type 2 diabetes mellitus	0.000121	0.000807	CcSEcCtD
Aminophylline—Nausea—Gliclazide—type 2 diabetes mellitus	0.000121	0.000805	CcSEcCtD
Aminophylline—Pruritus—Metformin—type 2 diabetes mellitus	0.00012	0.000803	CcSEcCtD
Aminophylline—Urticaria—Losartan—type 2 diabetes mellitus	0.00012	0.0008	CcSEcCtD
Aminophylline—Body temperature increased—Losartan—type 2 diabetes mellitus	0.00012	0.000796	CcSEcCtD
Aminophylline—Abdominal pain—Losartan—type 2 diabetes mellitus	0.00012	0.000796	CcSEcCtD
Aminophylline—Vomiting—Valsartan—type 2 diabetes mellitus	0.000119	0.000792	CcSEcCtD
Aminophylline—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000118	0.000789	CcSEcCtD
Aminophylline—Rash—Valsartan—type 2 diabetes mellitus	0.000118	0.000785	CcSEcCtD
Aminophylline—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000118	0.000785	CcSEcCtD
Aminophylline—Vomiting—Orlistat—type 2 diabetes mellitus	0.000117	0.000783	CcSEcCtD
Aminophylline—Insomnia—Ramipril—type 2 diabetes mellitus	0.000117	0.000781	CcSEcCtD
Aminophylline—Headache—Valsartan—type 2 diabetes mellitus	0.000117	0.00078	CcSEcCtD
Aminophylline—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000117	0.000776	CcSEcCtD
Aminophylline—Rash—Orlistat—type 2 diabetes mellitus	0.000117	0.000776	CcSEcCtD
Aminophylline—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000116	0.000775	CcSEcCtD
Aminophylline—Headache—Orlistat—type 2 diabetes mellitus	0.000116	0.000771	CcSEcCtD
Aminophylline—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000114	0.00076	CcSEcCtD
Aminophylline—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000114	0.000757	CcSEcCtD
Aminophylline—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000113	0.000751	CcSEcCtD
Aminophylline—Dizziness—Metformin—type 2 diabetes mellitus	0.000113	0.00075	CcSEcCtD
Aminophylline—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000111	0.000742	CcSEcCtD
Aminophylline—Nausea—Valsartan—type 2 diabetes mellitus	0.000111	0.00074	CcSEcCtD
Aminophylline—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.00011	0.000733	CcSEcCtD
Aminophylline—Nausea—Orlistat—type 2 diabetes mellitus	0.00011	0.000731	CcSEcCtD
Aminophylline—Vomiting—Metformin—type 2 diabetes mellitus	0.000108	0.000721	CcSEcCtD
Aminophylline—Rash—Metformin—type 2 diabetes mellitus	0.000107	0.000715	CcSEcCtD
Aminophylline—Dermatitis—Metformin—type 2 diabetes mellitus	0.000107	0.000715	CcSEcCtD
Aminophylline—Pruritus—Losartan—type 2 diabetes mellitus	0.000107	0.000713	CcSEcCtD
Aminophylline—Headache—Metformin—type 2 diabetes mellitus	0.000107	0.000711	CcSEcCtD
Aminophylline—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000106	0.000708	CcSEcCtD
Aminophylline—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000106	0.000706	CcSEcCtD
Aminophylline—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000103	0.000689	CcSEcCtD
Aminophylline—Urticaria—Ramipril—type 2 diabetes mellitus	0.000103	0.000686	CcSEcCtD
Aminophylline—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000103	0.000683	CcSEcCtD
Aminophylline—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000103	0.000683	CcSEcCtD
Aminophylline—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000102	0.000681	CcSEcCtD
Aminophylline—Rash—Irbesartan—type 2 diabetes mellitus	0.000101	0.000675	CcSEcCtD
Aminophylline—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000101	0.000674	CcSEcCtD
Aminophylline—Nausea—Metformin—type 2 diabetes mellitus	0.000101	0.000674	CcSEcCtD
Aminophylline—Headache—Irbesartan—type 2 diabetes mellitus	0.000101	0.000671	CcSEcCtD
Aminophylline—Dizziness—Losartan—type 2 diabetes mellitus	0.0001	0.000666	CcSEcCtD
Aminophylline—Vomiting—Losartan—type 2 diabetes mellitus	9.62e-05	0.000641	CcSEcCtD
Aminophylline—Hypersensitivity—Ramipril—type 2 diabetes mellitus	9.55e-05	0.000636	CcSEcCtD
Aminophylline—Nausea—Irbesartan—type 2 diabetes mellitus	9.55e-05	0.000636	CcSEcCtD
Aminophylline—Rash—Losartan—type 2 diabetes mellitus	9.54e-05	0.000635	CcSEcCtD
Aminophylline—Dermatitis—Losartan—type 2 diabetes mellitus	9.53e-05	0.000635	CcSEcCtD
Aminophylline—Headache—Losartan—type 2 diabetes mellitus	9.47e-05	0.000631	CcSEcCtD
Aminophylline—Pruritus—Ramipril—type 2 diabetes mellitus	9.17e-05	0.000611	CcSEcCtD
Aminophylline—Nausea—Losartan—type 2 diabetes mellitus	8.98e-05	0.000598	CcSEcCtD
Aminophylline—Diarrhoea—Ramipril—type 2 diabetes mellitus	8.87e-05	0.000591	CcSEcCtD
Aminophylline—Dizziness—Ramipril—type 2 diabetes mellitus	8.58e-05	0.000571	CcSEcCtD
Aminophylline—Vomiting—Ramipril—type 2 diabetes mellitus	8.24e-05	0.000549	CcSEcCtD
Aminophylline—Rash—Ramipril—type 2 diabetes mellitus	8.18e-05	0.000545	CcSEcCtD
Aminophylline—Dermatitis—Ramipril—type 2 diabetes mellitus	8.17e-05	0.000544	CcSEcCtD
Aminophylline—Headache—Ramipril—type 2 diabetes mellitus	8.12e-05	0.000541	CcSEcCtD
Aminophylline—Nausea—Ramipril—type 2 diabetes mellitus	7.7e-05	0.000513	CcSEcCtD
Aminophylline—ADORA2B—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.54e-06	7.23e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—RELA—type 2 diabetes mellitus	7.52e-06	7.21e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.46e-06	7.15e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CCL2—type 2 diabetes mellitus	7.45e-06	7.14e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PCK1—type 2 diabetes mellitus	7.44e-06	7.13e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	7.37e-06	7.06e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	7.37e-06	7.06e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.35e-06	7.04e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	7.32e-06	7.02e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.32e-06	7.02e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—AKT2—type 2 diabetes mellitus	7.32e-06	7.01e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.31e-06	7.01e-05	CbGpPWpGaD
Aminophylline—PDE4A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.31e-06	7.01e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.25e-06	6.95e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—CYP1A2—type 2 diabetes mellitus	7.21e-06	6.91e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—SLC2A1—type 2 diabetes mellitus	7.21e-06	6.91e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.2e-06	6.9e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	7.18e-06	6.88e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	7.15e-06	6.85e-05	CbGpPWpGaD
Aminophylline—PDE3A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.11e-06	6.82e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.05e-06	6.76e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—INS—type 2 diabetes mellitus	7.04e-06	6.74e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—CYP3A4—type 2 diabetes mellitus	7.03e-06	6.74e-05	CbGpPWpGaD
Aminophylline—HDAC2—Disease—SRC—type 2 diabetes mellitus	7.01e-06	6.72e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—IL6—type 2 diabetes mellitus	7e-06	6.71e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—HK1—type 2 diabetes mellitus	6.97e-06	6.68e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	6.96e-06	6.67e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—SRC—type 2 diabetes mellitus	6.95e-06	6.66e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.95e-06	6.66e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.92e-06	6.64e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—SLC2A4—type 2 diabetes mellitus	6.91e-06	6.63e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—GCG—type 2 diabetes mellitus	6.91e-06	6.63e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	6.85e-06	6.57e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	6.85e-06	6.57e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	6.85e-06	6.57e-05	CbGpPWpGaD
Aminophylline—ADORA1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6.85e-06	6.56e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.85e-06	6.56e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.81e-06	6.52e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.8e-06	6.52e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.79e-06	6.5e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.78e-06	6.49e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.77e-06	6.49e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.77e-06	6.49e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.74e-06	6.46e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	6.73e-06	6.45e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	6.73e-06	6.45e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	6.73e-06	6.45e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	6.73e-06	6.45e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.66e-06	6.38e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.64e-06	6.37e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.64e-06	6.36e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.64e-06	6.36e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.59e-06	6.32e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	6.57e-06	6.3e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	6.57e-06	6.3e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	6.47e-06	6.2e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.46e-06	6.19e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.46e-06	6.19e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	6.45e-06	6.18e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.41e-06	6.15e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.34e-06	6.08e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	6.32e-06	6.06e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	6.32e-06	6.06e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—SRC—type 2 diabetes mellitus	6.31e-06	6.05e-05	CbGpPWpGaD
Aminophylline—HDAC2—Disease—TGFB1—type 2 diabetes mellitus	6.27e-06	6.01e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	6.27e-06	6e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—RELA—type 2 diabetes mellitus	6.25e-06	5.99e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.22e-06	5.96e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.22e-06	5.96e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	6.21e-06	5.95e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.17e-06	5.91e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.17e-06	5.91e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.15e-06	5.89e-05	CbGpPWpGaD
Aminophylline—HDAC2—Disease—EGFR—type 2 diabetes mellitus	6.15e-06	5.89e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—SRC—type 2 diabetes mellitus	6.14e-06	5.89e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	6.14e-06	5.88e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	6.11e-06	5.85e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	6.11e-06	5.85e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	6.11e-06	5.85e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.09e-06	5.84e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	6.07e-06	5.82e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	6e-06	5.75e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.98e-06	5.73e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—GNB3—type 2 diabetes mellitus	5.96e-06	5.71e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.96e-06	5.71e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—HMOX1—type 2 diabetes mellitus	5.93e-06	5.69e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—SRC—type 2 diabetes mellitus	5.91e-06	5.67e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—CAT—type 2 diabetes mellitus	5.85e-06	5.61e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	5.81e-06	5.57e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.76e-06	5.52e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	5.74e-06	5.5e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—APOB—type 2 diabetes mellitus	5.68e-06	5.45e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.64e-06	5.41e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.64e-06	5.4e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	5.6e-06	5.37e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.53e-06	5.3e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—GSTM1—type 2 diabetes mellitus	5.53e-06	5.3e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.49e-06	5.26e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	5.48e-06	5.26e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	5.48e-06	5.26e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—LPL—type 2 diabetes mellitus	5.43e-06	5.2e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.38e-06	5.16e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	5.38e-06	5.15e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	5.38e-06	5.15e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	5.35e-06	5.12e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	5.34e-06	5.12e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	5.34e-06	5.12e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	5.34e-06	5.12e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.33e-06	5.1e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	5.31e-06	5.09e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—ADCY5—type 2 diabetes mellitus	5.31e-06	5.09e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—GPX1—type 2 diabetes mellitus	5.29e-06	5.07e-05	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.29e-06	5.07e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.28e-06	5.07e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.27e-06	5.05e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.24e-06	5.02e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	5.22e-06	5e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.21e-06	4.99e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	5.19e-06	4.98e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	5.19e-06	4.98e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	5.19e-06	4.98e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	5.19e-06	4.98e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.18e-06	4.97e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	5.16e-06	4.94e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—CD36—type 2 diabetes mellitus	5.16e-06	4.94e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PPP2CA—type 2 diabetes mellitus	5.09e-06	4.88e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	4.98e-06	4.77e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.95e-06	4.75e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—SRC—type 2 diabetes mellitus	4.91e-06	4.71e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.9e-06	4.69e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—MTHFR—type 2 diabetes mellitus	4.89e-06	4.68e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	4.81e-06	4.61e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.8e-06	4.6e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	4.79e-06	4.59e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	4.79e-06	4.59e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	4.79e-06	4.59e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PPARA—type 2 diabetes mellitus	4.79e-06	4.59e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.78e-06	4.58e-05	CbGpPWpGaD
Aminophylline—HDAC2—Disease—IL6—type 2 diabetes mellitus	4.72e-06	4.53e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	4.71e-06	4.51e-05	CbGpPWpGaD
Aminophylline—HDAC2—Gene Expression—AKT1—type 2 diabetes mellitus	4.69e-06	4.5e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—IL6—type 2 diabetes mellitus	4.68e-06	4.49e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	4.66e-06	4.47e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—AGT—type 2 diabetes mellitus	4.64e-06	4.45e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.63e-06	4.44e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.6e-06	4.41e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	4.56e-06	4.37e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—CALM1—type 2 diabetes mellitus	4.56e-06	4.37e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	4.56e-06	4.37e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—APOE—type 2 diabetes mellitus	4.55e-06	4.36e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—APOA1—type 2 diabetes mellitus	4.5e-06	4.31e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.45e-06	4.26e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.39e-06	4.21e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	4.38e-06	4.2e-05	CbGpPWpGaD
Aminophylline—HDAC2—Disease—AKT1—type 2 diabetes mellitus	4.36e-06	4.18e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	4.34e-06	4.16e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.32e-06	4.14e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	4.32e-06	4.14e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.3e-06	4.12e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—IL6—type 2 diabetes mellitus	4.25e-06	4.08e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	4.23e-06	4.06e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.23e-06	4.06e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	4.23e-06	4.05e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.21e-06	4.03e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	4.16e-06	3.98e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	4.16e-06	3.98e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	4.15e-06	3.98e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—IL6—type 2 diabetes mellitus	4.14e-06	3.97e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	4.12e-06	3.95e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	4.12e-06	3.95e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	4.12e-06	3.95e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4.1e-06	3.93e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.08e-06	3.91e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	4.03e-06	3.86e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	4e-06	3.83e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—IL6—type 2 diabetes mellitus	3.98e-06	3.82e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.98e-06	3.81e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PPARG—type 2 diabetes mellitus	3.96e-06	3.8e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.92e-06	3.76e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—INS—type 2 diabetes mellitus	3.89e-06	3.72e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.82e-06	3.66e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.7e-06	3.55e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.7e-06	3.55e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.7e-06	3.55e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.67e-06	3.52e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.63e-06	3.48e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.6e-06	3.45e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.58e-06	3.43e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	3.58e-06	3.43e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	3.57e-06	3.42e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—ALB—type 2 diabetes mellitus	3.56e-06	3.41e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.52e-06	3.38e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	3.52e-06	3.37e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	3.42e-06	3.27e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.41e-06	3.27e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—NOS3—type 2 diabetes mellitus	3.41e-06	3.27e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.38e-06	3.24e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.35e-06	3.21e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.35e-06	3.21e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	3.32e-06	3.18e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—IL6—type 2 diabetes mellitus	3.31e-06	3.17e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	3.26e-06	3.13e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.21e-06	3.07e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.21e-06	3.07e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	3.19e-06	3.06e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	3.18e-06	3.05e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PTGS2—type 2 diabetes mellitus	3.12e-06	2.99e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	3.1e-06	2.97e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	3.07e-06	2.95e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	3.06e-06	2.93e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.05e-06	2.92e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	2.94e-06	2.81e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	2.88e-06	2.76e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.84e-06	2.72e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	2.79e-06	2.67e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.76e-06	2.65e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.76e-06	2.65e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.75e-06	2.64e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	2.74e-06	2.63e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	2.73e-06	2.62e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.72e-06	2.6e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	2.7e-06	2.59e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.64e-06	2.53e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.56e-06	2.46e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.52e-06	2.41e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.46e-06	2.36e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.46e-06	2.35e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.39e-06	2.29e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	2.38e-06	2.28e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.36e-06	2.26e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	2.34e-06	2.24e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.27e-06	2.17e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.22e-06	2.13e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.15e-06	2.06e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	2.14e-06	2.05e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.12e-06	2.03e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.11e-06	2.02e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.09e-06	2e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.05e-06	1.96e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	2.05e-06	1.96e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.87e-06	1.8e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.84e-06	1.76e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.8e-06	1.73e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.65e-06	1.58e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.58e-06	1.52e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.58e-06	1.52e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—AKT1—type 2 diabetes mellitus	1.57e-06	1.5e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.45e-06	1.39e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	9.42e-07	9.02e-06	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	7.27e-07	6.96e-06	CbGpPWpGaD
